Wafae Iraqi

1.4k total citations
17 papers, 847 citations indexed

About

Wafae Iraqi is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Wafae Iraqi has authored 17 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Wafae Iraqi's work include Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Hepatitis C virus research (4 papers). Wafae Iraqi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Hepatitis C virus research (4 papers). Wafae Iraqi collaborates with scholars based in France, United Kingdom and Belgium. Wafae Iraqi's co-authors include Faı̈ez Zannad, Renaud Fay, Patrick Rossignol, Patrick Rossignol, Bertram Pitt, J M Ketelslegers, John Vincent, Michaël Angioı̈, Vincent Delwail and Antoine Martin and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Wafae Iraqi

16 papers receiving 827 citations

Peers

Countries citing papers authored by Wafae Iraqi

Since Specialization

Citations

This map shows the geographic impact of Wafae Iraqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafae Iraqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafae Iraqi more than expected).

Fields of papers citing papers by Wafae Iraqi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wafae Iraqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafae Iraqi. The network helps show where Wafae Iraqi may publish in the future.

Co-authorship network of co-authors of Wafae Iraqi

This figure shows the co-authorship network connecting the top 25 collaborators of Wafae Iraqi. A scholar is included among the top collaborators of Wafae Iraqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafae Iraqi. Wafae Iraqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe 2024 ·Patient Preference and Adherence ·Valeria Magarotto, Julien Thévenon, Kate Morgan, (unknown), Wafae Iraqi, (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	The Burden of a Multiple Myeloma Diagnosis on Patients and Caregivers in the First Year: Western European Findings 2022 ·ClinicoEconomics and Outcomes Research ·(unknown), Wafae Iraqi, Kate Morgan, (unknown), (unknown), (unknown), (unknown)	4
3	Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia 2021 ·Oncology and Therapy ·Gordon Cook, Alessandro Corso, Matthew Streetly, Л. П. Менделеева, В. В. Птушкин, Edmond S. Chan, Jon Ukropec, Wafae Iraqi, (unknown), Huiling Pei, (unknown), Maria Teresa Petrucci, Adrían Alegre, María‐Victoria Mateos	6
4	Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia 2019 ·Annals of Hematology ·Gilles Salles, Emmanuel Bachy, Lukáš Smolej, Martin Šimkovič, Lucile Baseggio, (unknown), Hervé Besson, (unknown), (unknown), Wafae Iraqi, Joris Diels, (unknown), Martin Špaček, (unknown), Daniel Lysák, (unknown), (unknown), Evelyne Callet‐Bauchu, Michael Doubek	11
5	PS1425 RESULTS OF THE DARATUMUMAB MONOTHERAPY EARLY ACCESS TREATMENT PROTOCOL (EAP) IN PATIENTS FROM EUROPE AND RUSSIA WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA 2019 ·HemaSphere ·Gary Cook, Alessandro Corso, Matthew Streetly, Л. П. Менделеева, (unknown), (unknown), (unknown), Wafae Iraqi, (unknown), Huiling Pei, (unknown), MT Petrucci, Adrían Alegre, María‐Victoria Mateos	2
6	PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies 2017 ·Journal of Comparative Effectiveness Research ·(unknown), (unknown), Hervé Besson, (unknown), Finlay MacDougall, (unknown), Joris Diels, Wafae Iraqi	6
7	Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONATETM and RESONATE-2TM with the French Lyon-Sud Database 2016 ·Blood ·Gilles Salles, Lucile Baseggio, Emmanuel Bachy, Clémentine Sarkozy, Hervé Ghesquières, Joris Diels, Hervé Besson, Finlay MacDougall, (unknown), (unknown), (unknown), Wafae Iraqi, Evelyne Callet‐Bauchu	0
8	Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis 2015 ·PLoS ONE ·(unknown), Massimo Colombo, Inmaculada Fernández, (unknown), Paulo Roberto Abrão Ferreira, Simone I. Strasser, Petr Urbánek, Alessandra Mangia, José Luís Calleja, Wafae Iraqi, Ralph DeMasi, Isabelle Lonjon‐Domanec, Christophe Moreno, Heiner Wedemeyer	7
9	Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program 2014 ·Journal of Hepatology ·Massimo Colombo, Simone I. Strasser, Christophe Moreno, Paulo Roberto Abrão Ferreira, Petr Urbánek, Inmaculada Fernández, (unknown), Adrian Streinu‐Cercel, (unknown), Wafae Iraqi, Ralph DeMasi, Andrew F. Hill, Isabelle Lonjon‐Domanec, Heiner Wedemeyer	24
10	Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C 2013 ·Gut ·M. Colombo, Inmaculada Fernández, (unknown), Paulo Roberto Abrão Ferreira, Simone I. Strasser, Petr Urbánek, Christophe Moreno, Adrian Streinu‐Cercel, (unknown), Wafae Iraqi, Ralph DeMasi, Andrew Hill, J.M. Läuffer, Isabelle Lonjon‐Domanec, Heiner Wedemeyer	42
11	806 MANAGEMENT AND OUTCOMES OF ANEMIA IN THE INTERNATIONAL TELAPREVIR EARLY ACCESS PROGRAM, FOR PATIENTS WITH HEPATITIS C GENOTYPE 1 INFECTION 2013 ·Journal of Hepatology ·Massimo Colombo, (unknown), (unknown), (unknown), Simone I. Strasser, Petr Urbánek, (unknown), Adrian Streinu‐Cercel, F Beeldens, Wafae Iraqi, Ralph DeMasi, Adrian V. S. Hill, J.M. Läuffer, Isabelle Lonjon‐Domanec, H. Wedemeyer	5
12	Association of Galectin-3 and Fibrosis Markers with Long-Term Cardiovascular Outcomes in Patients with Heart Failure, Left Ventricular Dysfunction, and Dyssynchrony: Insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial 2011 ·European Journal of Heart Failure ·Natalia López‐Andrés, Patrick Rossignol, Wafae Iraqi, Renaud Fay, (unknown), Stefano Ghio, John G.F. Cleland, Faı̈ez Zannad, Patrick Lacolley	180
13	Extracellular matrix fibrotic markers in heart failure 2009 ·Heart Failure Reviews ·Faı̈ez Zannad, Patrick Rossignol, Wafae Iraqi	67
14	H016 Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the ephesus study 2009 ·Archives of cardiovascular diseases ·Patrick Rossignol, Wafae Iraqi, Michaël Angioı̈, Renaud Fay, (unknown), J M Ketelslegers, John Vincent, Bertram Pitt, F Zannad	2
15	Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure 2009 ·Circulation ·Wafae Iraqi, Patrick Rossignol, Michaël Angioı̈, Renaud Fay, (unknown), J M Ketelslegers, John Vincent, Bertram Pitt, Faı̈ez Zannad	198
16	A multifactorial strategy of pain management is associated with less pain in scheduled vaccination of children. A study realized by family practitioners in 239 children aged 4-12 years old 2008 ·Family Practice ·Jean‐Marc Boivin, (unknown), Wafae Iraqi, Renaud Fay, Claudine Schmitt, P. Rossignol	21
17	A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases 2005 ·Blood ·Sophie Camilleri‐Broët, Emmanuelle Crinière, Philippe Broët, Vincent Delwail, Karima Mokhtari, Anne Moreau, M. Kujas, Martine Raphaël, Wafae Iraqi, Catherine Sautès‐Fridman, Philippe Colombat, Khê Hoang‐Xuan, Antoine Martin	271

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact